Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Agnosia × Clear all

Phase

Phase NA 155 Phase 4 22 Phase 3 18 Phase 2 18 Phase 2/3 5 Phase 1/2 3 Phase 1 3 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 181 Neoplasms 113 Prostatic Neoplasms 101 Multiple Myeloma 83 Glioblastoma 80 Pancreatic Neoplasms 74 Glioma 65 Brain Neoplasms 60 Lung Neoplasms 58 Head and Neck Neoplasms 57 Melanoma 53 Carcinoma, Non-Small-Cell Lung 53 Colorectal Neoplasms 52 Leukemia, Myeloid, Acute 50 Carcinoma, Hepatocellular 48 Squamous Cell Carcinoma of Head and Neck 46 Recurrence 45 Ovarian Neoplasms 45 Lymphoma 39 Lymphoma, Non-Hodgkin 37 Sarcoma 35 Stomach Neoplasms 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Neoplasm Metastasis 33 Lymphoma, B-Cell 32 Solid Tumor 31 Hematologic Neoplasms 31 Carcinoma, Renal Cell 30 Polycystic Ovary Syndrome 27 Burkitt Lymphoma 27

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03317730 2021-07-20

RAD 1702

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed

Agnosia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡